President-elect Trump’s vows to seek revenge have brought a renewed sense of alarm to those who have crossed ways with him ...

Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, presented data at the International Oncolytic Virotherapy ...

Researchers found that inhibiting the enzyme TYK2 may reduce the harmful accumulation of tau protein in Alzheimer’s disease, ...

“Better risk management, information sharing amongst agencies, and faster clearance would all contribute to reducing ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare ...

The Nigeria Customs Service (NCS) says it has achieved its 2024 revenue target of N5.07 trillion. Adewale Adeniyi, ...